Você está na página 1de 3

INSTRUCTIONS FOR POSTER PRESENTATIONS

SIZE POSTER BOARDS 4' high and 8' wide (landscape)

USize of usable space on poster board: 91" wide x 44 1/2" high

Layout: landscape

PREPARING YOUR POSTER


Text on poster
Indicate on the poster in a table (4 inches high and 6 inches wide) in the Right-upper corner:
- Whether your work is original or confirmatory
- The quality of evidence (the WGC Rating system for grading the quality of evidence and
glossary are mentioned on page 3)

EXAMPLE:

EVIDENCE LEVEL I / II / III


ORIGINAL / CONFIRMATORY

Use a clear typeface and, if possible, a laser printer.


The poster should be readable from a distance of 8- 10 feet. This means that all lettering
should be at least 32 Pt. ( 3 inches high).
Please prepare a title banner for your poster to be put across the top of the poster board. The
title banner should be 4 inches high and 57 inches wide and should state the title of the
presentation and the name(s) and affiliations(s) of the author(s). Lettering on the banner should
be at least 80 Pt. (0.8 inch high).

Graphs and diagrams


Graphs and figures should be readable from a distance of 8 10 feet.
They should be drawn with a minimum line width of 0.4 inch

World Glaucoma Congress


AT THE CONGRESS
It should be emphasized that the WGC has purposely chosen scientific posters as the major mode of
free, original presentations at the congress. Posters are an excellent and important way of providing
scientific information. The WGC is making an effort to provide high visibility for the posters, by
declaring them to be the exclusive medium for free presentation.
For this reason the Program Committee have created the following options to pay ample attention to
the posters:

1. Top 30 nomination
2. Top 10 nomination
3. Top-three Poster Recognitions
4. Attention sign

GENERAL INFORMATION

One poster board will be allocated for each poster presentation.


A printed number identifying each poster board will be provided.
Colour of poster board: grey flannel

Registration
Please remember to register for the Congress in order to be allowed to mount your poster
(TUwww.worldglaucoma.orgU)T .

Location
Posters will be presented in the Poster Area, which is located in Hall B of the Hynes Convention
Center.

Poster Mounting
Posters should be mounted UWednesday July 8, between 8.00 12.00 AMU. All posters should be mounted at
12.00 AM
Posters should be mounted with push pins, which are available at the poster desk.
Assistance and material for mounting the posters (tape) will be available from set-up time (see below), at the
poster desk in the poster area.
The poster area is open for poster viewing from Wednesday July 18, 12.00 (noon) until Saturday July 11, 12.00
(noon).

Authors are requested to indicate on their posters the hours that they will be available at their
poster. This usually will be during one of the breaks.

Removing your poster material


Posters should be removed before 3.00 PM on Saturday July 11.
Posters that have not been taken down by the author(s) will be removed and destroyed by the WGC Congress
Organizer Meeting Office.

World Glaucoma Congress


World Glaucoma Congress Rating System for Grading the Quality
of Evidence and Glossary (adapted from AAO)
Quality of Evidence:

Level I: (Interventional) Evidence obtained from at least one properly done, well-designed
randomized controlled trial or meta-analyses of high quality randomized controlled trials*.
(Observational) Evidence obtained from well-done population-based prevalence or incidence
studies.

Level II: (Interventional) Evidence obtained from well-done non-randomized comparative trials or well-
done systematic literature reviews summarizing primarily level II publications.
(Observational) Evidence obtained from high quality case-control and cohort studies

Level III: (Interventional or Observational) Evidence obtained from non-comparative case series, case
reports, and expert or consensus opinion.

The overall level of evidence rating cannot exceed that of the individual studies reviewed. All literature
assessed is assumed to be peer reviewed.

Glossary:

case-control study An observational (non-interventional, usually retrospective) study that begins by


identifying individuals with a disease (cases) for comparison to individuals without a disease (controls
or reference group), in which analysis proceeds from effect to cause.

case report Usually a retrospective report of a single interventional or observational case experience,
often with clinical-pathological correlation.

case series Case series include those studies describing more than one consecutive or non-
consecutive cases, studied retrospectively or prospectively, usually with regard to the outcome of an
intervention for its efficacy, safety, and complications. Non-comparative case series generally have no
control group included but outcome may be compared to that in the literature.

cohort study An observational study that begins by identifying individuals with (study group) and
without (control group) a factor being investigated to observe over time with regard to disease
outcome; study and control groups may be concurrent or non-concurrent but must be derived from the
same well defined cohort; almost always prospective with regard to data collection. Almost always
longitudinal in that a particular group of patients is followed forward from a point in time. May or may
not be population-based.

comparative study Study including two or more defined groups, compared one to another, to make a
judgment about the influence of some factor or treatment.

cross-sectional study An observational study that identifies individuals with and without the condition
or exposure being studied at the same time (synonymous with prevalence study). May or may not be
population-based.

interventional study A study that includes an attempt to alter the course of disease by medical or
surgical or other therapy.

observational study No intervention or attempt to alter the natural course of disease or physical
condition.

World Glaucoma Congress